Use of Specific T Lymphocytes in Treating Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients: A Systematic Review

Use of Specific T Lymphocytes in Treating Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients: A Systematic Review

Cytomegalovirus (CMV) poses a significant threat to post-hematopoietic cell transplantation (HCT). Control strategies include letermovir prophylaxis or ganciclovir pre-emptive therapy (PET). Without prophylaxis, 65–90% of seropositive recipients develop a clinically significant CMV infection. Due to...

Full description

Bibliographic Details
Main Authors: Tayná F. G. S. Bandeira, Luciana C. Marti, Edna T. Rother, Lucas Reis Correia, Clarisse M. Machado
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Pharmaceutics
Subjects:
specific T lymphocytes
hematopoietic cell transplant
cytomegalovirus infection
Online Access:https://www.mdpi.com/1999-4923/16/10/1321

Internet

https://www.mdpi.com/1999-4923/16/10/1321

Similar Items